Predictive factors of response to leukocytapheresis therapy for ulcerative colitis

Ther Apher. 1998 May;2(2):115-9. doi: 10.1111/j.1744-9987.1998.tb00087.x.

Abstract

Leukocytapheresis (LCAP) using a leukocyte removal filter was performed for 8 patients with moderate to severe ulcerative colitis (UC). Significant clinical improvement was attained in 5 of 8 patients (62.5%). All of them had been suffering from moderately active colitis and received corticosteroid therapy. On the other hand, 3 patients with severely active disease and treated with little or no corticosteroid were resistant to LCAP. This result indicates that LCAP is an effective treatment for steroid-resistant cases of UC when combined with steroid therapy. LCAP alone, however, seems to have little efficacy for severely active UC.

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Colitis, Ulcerative / therapy*
  • Combined Modality Therapy
  • Female
  • Humans
  • Leukapheresis*
  • Male
  • Predictive Value of Tests
  • Prednisolone / therapeutic use
  • Sulfasalazine / therapeutic use

Substances

  • Anti-Inflammatory Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Sulfasalazine
  • Prednisolone